DUBAI- Dr Javad Parvizi, Professor and Vice Chairman, Rothman Institute, Thomas Jefferson University, Philadelphia, USA, and title holder of the World’s Top Specialist in Hip Replacement 2014 spoke today at the 3rd International Congress for Joint Reconstruction – Middle East 2014 (ICJR Middle East) about the causes and treatment of chronic instability after total hip replacement procedures.
ICJR Middle East, organised by Informa Life Sciences Exhibitions, continues on 2 May 2014 at the Dubai International Convention & Exhibition Centre and is the region’s largest gathering of joint surgery and sports injury specialists.
Dr Parvizi is the Director and Vice Chairman of clinical research at Rothman Institute and Thomas Jefferson University with interest in reconstruction of complex pelvis, hip, and knee diseases with special emphasis on joint preservation. As the Vice Chair for Research, he oversees the operations of clinical and basic science research. He has extensive experience on conducting clinical trials and outcome studies on joint replacement patients. He is also actively involved in basic science research in tissue engineering and has received numerous grants from the National Institute of Health, Department of Defense, and other funding bodies for his work on development of self-protective smart orthopedic implants and molecular diagnosis of periprosthetic joint infection.
“We are very pleased and privileged to host Dr Parvizi at ICJR Middle East this year. We are confident that his contribution to the field of orthopaedic surgery in the world, and in the Middle East will be recognized amongst his peers and patients alike,” highlighted Simon Page, Managing Director, Informa Life Sciences Exhibitions.
According to Dr Parvizi, “Dislocation after total hip arthroplasty is a distressful complication for both the patient and the surgeon. Although prevention of hip instability is considered to be of utmost importance by orthopedic surgeon, dislocation remains the second most common complications of total hip arthroplasty. Dislocation after primary THA occurs in 0.3% to more than 10% and in up to 28% of patients after revision THA. For treatment purposes, dislocation after THA can be placed into two temporal categories—early and late—based on the timing of onset. Early dislocation usually occurs in the early postoperative period (less than six months) after the primary arthroplasty. More than half of dislocations occur within the first 3 months postoperatively and more than three fourth occur within 1 year. Early dislocations are often successfully treated with conservative management and carry a better prognosis with a lower rate of recurrence. In comparison, late dislocations occur later usually after five years and have a multifactorial etiology including polyethylene wear and soft tissue laxity. The management of late dislocation generally requires surgical intervention.”
Dr Parvizi is joined at ICJR Middle East by his colleagues from the region and across the globe, including Dr Yaqoob Al Hammadi from the Sheikh Khalifa Medical City; Dr Nader Darwich from the Abu Dhabi Knee and Sports Medicine Center; and Dr Fares Haddad, Professor of Orthopaedics, from the University College London, London, UK.